Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Kalyn Collard

Pediatrics Lake Jackson, TX Medical Doctor

NPI 1316474661 CMS profile 3735567

210 Lake Rd Ste 600, Lake Jackson, TX 77566

Open in the dashboard

General payments

$1,986

131 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kalyn Collard of Lake Jackson, TX is reported in the CMS Open Payments database as having received $1,986 across 131 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $483 34
2024 General $343 23
2023 General $355 26
2022 General $327 20
2021 General $270 16
2020 General $208 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kalyn Collard
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Kalyn Collard were reported at $483. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Kalyn Collard Pediatrics median Middle half National median
2019 $0 $86 $31–$183 $163
2020 $208 $49 $22–$110 $114
2021 $270 $68 $27–$158 $132
2022 $327 $77 $30–$173 $149
2023 $355 $88 $33–$190 $160
2024 $343 $94 $34–$206 $164
2025 $483 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Corium, Inc. $453 24 payments
  2. Tris Pharma Inc $355 23 payments
  3. Supernus Pharmaceuticals, Inc. $316 21 payments
  4. Ironshore Pharmaceuticals Inc. $249 19 payments
  5. Collegium Pharmaceutical, Inc. $137 17 payments
  6. Cranial Technologies, Inc $92 6 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $85 4 payments
  8. GlaxoSmithKline, LLC. $59 4 payments
  9. Merck Sharp & Dohme Corporation $58 3 payments
  10. Neos Therapeutics, LP $51 3 payments
  11. Other $131 7 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $1,986 131 payments
Products named General payments · program years 2020–2025
  1. Azstarys $453 24 payments
  2. Qelbree $222 15 payments
  3. JORNAY PM Central Nervous System Stimulant $179 15 payments
  4. Quillivant $156 10 payments
  5. Jornay PM Adhd $137 17 payments
  6. Doc Band $92 6 payments
  7. VYVANSE $85 4 payments
  8. JORNAY PM Central Nervous Stimulant ADHD $70 4 payments
  9. Quillivant XR $70 5 payments
  10. BEXSERO $59 4 payments
  11. Other $587 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record